Faculty who have authored publication Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial.
| Name | Title | Department | Institution |
|---|---|---|---|
| Kenneth Brian Gordon MD | Chair, Professor | Dermatology | Medical College of Wisconsin |
